Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2019-04-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
“18瑞康01”公司债券2019年付息公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the interest payment for a corporate bond issued by 瑞康医药集团股份有限公司 (Ruikang Pharmaceutical Group Co., Ltd.). It details the bond's basic information, interest rate, payment dates, tax implications, and contact information. The document does not contain financial statements or comprehensive financial data but rather focuses on the bond interest payment event and related procedural details. It is not an annual or interim report, audit report, earnings release, or any other financial report type. It is a specific update on a financing instrument (corporate bond) and its interest payment, which fits the category of Capital/Financing Update (CAP). The document length is about 4830 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the appropriate classification is CAP with high confidence.
2019-04-15 Chinese
2019年第二次临时股东大会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2019 second extraordinary general meeting of shareholders of 瑞康医药集团股份有限公司. It details the meeting date, attendance, voting results on specific proposals, and legal opinion on the meeting's validity. There is no financial data or report content, only the official voting results and meeting procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2019-04-08 Chinese
2019年第二次临时股东大会的律师见证法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2019 second extraordinary general meeting (EGM) of shareholders of Ruikang Pharmaceutical Group Co., Ltd. It details the legal verification of the convening, attendance, agenda, voting procedures, and results of the shareholders' meeting. The document does not contain financial statements or financial performance data but focuses on the legality and procedural correctness of the shareholders' meeting and its resolutions. This type of document is a legal proceedings report related to corporate governance and shareholder meetings, not an annual report, earnings release, or other financial report. Therefore, the appropriate classification is Legal Proceedings Report (LTR).
2019-04-08 Chinese
关于2018年第一期员工持股计划的进展公告
Capital/Financing Update Classification · 95% confidence The document is a progress announcement regarding the company's 2018 first employee stock ownership plan. It details the number of shares bought, the transaction amount, and compliance with disclosure regulations. The document is short (1055 characters) and focuses on the update of a capital-related activity (employee stock ownership plan implementation and share purchases). It is not a full financial report, audit, or earnings release. It is not a notice of voting results or management changes. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes through employee stock plans.
2019-04-03 Chinese
关于股份回购的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It references previous approvals and disclosures about the share buyback but primarily provides an update on the status of the repurchase account and the fact that no repurchase operations have yet been conducted. The document is short (920 characters) and focuses on the progress of a share repurchase program, which aligns with the category for reports on company buying back or selling its own shares. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2019-04-03 Chinese
关于股东权益变动的进展公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from 瑞康医药集团股份有限公司 regarding changes in shareholder equity, specifically detailing share disposals by a major shareholder (汇添富基金) and related transactions. It includes specific share quantities, percentages, transaction dates, and prices. The document references previous announcements and regulatory compliance with Chinese securities regulations. The content focuses on changes in share ownership and disclosures related to significant shareholders' transactions. It does not contain financial statements, earnings data, or management discussion. The document length is 2730 characters, which is relatively short and typical for a shareholder equity change announcement. Therefore, the document fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2019-03-26 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.